CRISPR Assays for Disease Diagnosis: Progress to and Barriers Remaining for Clinical Applications
Abstract: Numerous groups have employed the special properties of CRISPR/Cas systems to develop platforms that have broad potential applications for sensitive and specific detection of nucleic acid (NA) targets. However, few of these approaches have progressed to commercial or clinical applications. This review summarizes the properties of known CRISPR/Cas systems and their applications, challenges associated with the development of such assays, and opportunities to improve their performance or address unmet assay needs using nano‐/micro‐technology platforms. These include rapid and efficient sample preparation, integrated single‐tube, amplification‐free, quantifiable, multiplex, and non‐NA assays. Finally, this review discusses the current outlook for such assays, including remaining barriers for clinical or point‐of‐care applications and their commercial development.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
CRISPR Assays for Disease Diagnosis: Progress to and Barriers Remaining for Clinical Applications ; day:10 ; month:05 ; year:2023 ; extent:16
Advanced science ; (10.05.2023) (gesamt 16)
- Creator
-
Huang, Zhen
Lyon, Christopher J.
Wang, Jin
Lu, Shuihua
Hu, Tony Y.
- DOI
-
10.1002/advs.202301697
- URN
-
urn:nbn:de:101:1-2023051015365577644903
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Huang, Zhen
- Lyon, Christopher J.
- Wang, Jin
- Lu, Shuihua
- Hu, Tony Y.